Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-000903
Filing Date
2024-01-09
Accepted
2024-01-09 10:27:57
Documents
15
Period of Report
2024-01-09

Document Format Files

Seq Description Document Type Size
1 6-K a240109_6kxmorxvotingright.htm 6-K 12024
2 EX-99.1 exhibit_991.htm EX-99.1 15484
3 EX-99.2 exhibit_992.htm EX-99.2 15823
4 GRAPHIC exhibit_991001.jpg GRAPHIC 127171
5 GRAPHIC exhibit_991002.jpg GRAPHIC 128238
6 GRAPHIC exhibit_991003.jpg GRAPHIC 123079
7 GRAPHIC exhibit_991004.jpg GRAPHIC 89568
8 GRAPHIC exhibit_991005.jpg GRAPHIC 101983
9 GRAPHIC exhibit_991006.jpg GRAPHIC 27883
10 GRAPHIC exhibit_992001.jpg GRAPHIC 129145
11 GRAPHIC exhibit_992002.jpg GRAPHIC 125262
12 GRAPHIC exhibit_992003.jpg GRAPHIC 122812
13 GRAPHIC exhibit_992004.jpg GRAPHIC 91630
14 GRAPHIC exhibit_992005.jpg GRAPHIC 98434
15 GRAPHIC exhibit_992006.jpg GRAPHIC 46041
  Complete submission text file 0001628280-24-000903.txt   1713545
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 24522093
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)